Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_provenance.
- NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_assertion description "[Our findings therefore argue that interference with MKK3 signaling through a novel treatment combination of p38 inhibitor plus temozolomide heightens the vulnerability of glioma to chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_provenance.
- NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_assertion evidence source_evidence_literature NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_provenance.
- NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_assertion SIO_000772 17406030 NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_provenance.
- NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_assertion wasDerivedFrom befree-20140225 NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_provenance.
- NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_assertion wasGeneratedBy ECO_0000203 NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP238522.RA2IxS-PUNj8nkk_cXTaM-kZ9Mp_EOz3A5wVuSYC5Evnw130_provenance.